IBEX 35
10.995,70 +78,20 (+0,72%) Euro Stoxx 50
4.986,52 +29,56 (+0,60%) Dólar/Euro
1,0763 -0,0010 (-0,10%) Petróleo Brent
83,23 -0,10 (-0,12%) Oro
2.322,90 -8,30 (-0,36%) Bitcoin EUR
59.593,91 -968,72 (-1,60%)
Integer Holdings Corporation (ITGR)
Después del cierre:
Integer Holdings Corporation
5830 Granite Parkway
Suite 1150
Plano, TX 75024
United States
214 618 5243
https://www.integer.net
Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 10.500
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Joseph W. Dziedzic | President, CEO & Director | 3,24M | 713,51k | 1968 |
| Mr. Diron Smith | Executive VP & CFO | 651,22k | N/A | 1974 |
| Mr. McAlister C. Marshall II | Senior VP, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary | 854,89k | N/A | 1970 |
| Mr. Kirk K. Thor | Executive VP & Chief Human Resources Officer | 791,64k | N/A | 1964 |
| Mr. Payman Khales | President of Cardio & Vascular | 1,14M | N/A | 1970 |
| Mr. John Harris | Executive Vice President of Global Operations & Manufacturing Strategy | 521,18k | 42,65k | 1960 |
| Mr. Tom P. Thomas | VP, Corporate Controller & Principal Accounting Officer | N/A | N/A | 1971 |
| Mr. Andrew Senn | Senior Vice President of Strategy, Business Development & Investor Relations | N/A | N/A | 1982 |
| Ms. Margaret Carthy | Executive VP of Global Quality & Regulatory Affairs | N/A | N/A | 1964 |
| Mr. Jim Stephens | President of Cardiac Rhythm Management & Neuromodulation | N/A | N/A | 1974 |
Descripción
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Gobierno corporativo
El ISS Governance QualityScore de Integer Holdings Corporation, a día 1 de mayo de 2024, es 2. Las puntuaciones base son Auditoría: 4; Tablero: 2; Derechos de los accionistas: 2; Compensación: 3.
